Foamix Pharmaceuticals Ltd. Cashflow Statement

Ask AI

Overview Financial Statements SEC Filings Executives News Red Flags Capital Raising Ownership Insider Transactions Congressional Trades

Financial Statements

Income Statement Balance Sheet Cashflow Statement

Consolidated statements of cash flows

In millions of USD, except per-share amounts

	FY2019 12 months to Dec 31, 2019	FY2018 12 months to Dec 31, 2018	FY2017 12 months to Dec 31, 2017	FY2016 12 months to Dec 31, 2016	FY2015 12 months to Dec 31, 2015
CASH FLOWS FROM OPERATING ACTIVITIES:
Net Loss
Adjustments required to reconcile net loss to net cash used in operating activities:
Depreciation and amortization
Loss from sale and disposal of fixed assets
Changes in marketable securities and bank deposits, net
Changes in accrued liability for employee severance benefits, net of retirement fund profit
Share-based compensation
Non-cash finance expenses (income), net
Changes in operating asset and liabilities:
Decrease (increase) in trade and other receivables
Decrease (increase) in other non-current assets
Increase in accounts payable and accruals
Net cash used in operating activities
Increase in inventory
Increase (decrease) in other liabilities
Net cash used in operating activities

CASH FLOWS FROM INVESTING ACTIVITIES:
Purchase of fixed assets
Proceeds from sale of fixed assets
Investment in bank deposits
Investment in marketable securities
Proceeds from sale and maturity of marketable securities and bank deposits
Net cash provided by (used in) investing activities
CASH FLOWS FROM FINANCING ACTIVITIES:
Proceeds from exercise of warrants
Proceeds from exercise of options and issuance of shares under the employee shares purchase plan
Withholding tax from net exercise of restricted share units
Proceeds from issuance of Ordinary Shares, net of issuance costs
Proceeds from issuance of Ordinary Shares through a public offering, net of $5.2 issuance costs
Proceeds from debt financing and issuance of warrants, net of $1,097 issuance costs
Payments in respect of BIRD loan
Payments in respect of bank borrowings
Net cash provided by financing activities

INCREASE (DECREASE) IN CASH, CASH EQUIVALENTS AND RESTRICTED CASH
EFFECT OF EXCHANGE RATE ON CASH, CASH EQUIVALENTS AND RESTRICTED CASH
CASH, CASH EQUIVALENTS AND RESTRICTED CASH AT BEGINNING OF THE YEAR
CASH, CASH EQUIVALENTS AND RESTRICTED CASH AT END OF THE YEAR
Cash and cash equivalents
Restricted cash
TOTAL CASH, CASH EQUIVALENTS AND RESTRICTED CASH SHOWN IN STATEMENT OF CASH FLOWS
SUPPLEMENTARY INFORMATION ON INVESTING AND FINANCING ACTIVITIES NOT INVOLVING CASH FLOWS:
Cashless exercise of warrants and restricted share units
Issuance of shares under employee share purchase plan
Exercise of restricted share units
Property and equipment purchases included in accounts payable and accruals
Additions to operating lease right of use assets and liabilities
SUPPLEMENTAL DISCLOSURE OF CASH FLOW INFORMATION:
Cash paid for taxes
Interest received
Interest paid

Comments